Abstract
The rational discovery of a high affinity NK 2 receptor antagonist is described utilizing a general strategy for peptoid design. The contribution to NK 2 receptor binding affinity for each amino acid of the hexapeptide ‘inimum fragment’: Leu-Met-Gln-Trp-Phe-GlyNH 2 ( 8c), was examined by preparing derivatives where each amino acid in turn was replaced with Ala in an ‘alanine scan’. The results from this study indicated the primary importance of the Trp and Phe side-chain for binding and led to the observation that Z-Trp-PheNH 2 ( 9a) is a micromolar affinity NK 2 receptor dipeptide lead. Further exploration of structure-affinity via conformationally restricted analogues and N- and C-terminus modifications gave a selective, nanomolar affinity NK 2 receptor antagonist, (2,3di-CH 3OPh)CH 2OCO( S)Trp( S)α-MePheGlyNH 2, PD 147714 ( 19) with an K i = 1.4 nM (hamster urinary bladder membranes and using [ 125I]-iodohistidyl-NKA (0.1 nM) as the radioligand).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.